Results 101 to 110 of about 110,265 (199)

Destination therapy with a left ventricular assist device for end-stage heart failure patients. A single center ten-year experience

Hellenic Journal of Cardiology, 2023
Filippos-Paschalis Rorris, Constantine N. Antonopoulos, Dimitra Koutsavli, Aikaterini Psevdi, Zafeiria J. Margari, Michalis Tsamatsoulis, Ilias Samiotis, Michalis Argiriou, Christos Charitos   +8 more
doaj   +1 more source

Correction to: Sex Differences in Recovery and Device Replacement After Left Ventricular Assist Device Implantation as Destination Therapy. [PDF]

J Am Heart Assoc, 2022
europepmc   +1 more source

Life experiences and coping strategies after left ventricular assist device implantation as destination therapy in China: a descriptive phenomenological inquiry. [PDF]

BMJ Open
Shi A, Gan S, Liu S, Li F, Zhang X, Shi Y.   +5 more
europepmc   +1 more source

An infectious disease perspective-is destination therapy a viable option for total artificial hearts? [PDF]

Ann Cardiothorac Surg, 2020
Zabner R, Lam LD, Runyan C.
europepmc   +1 more source

Stellate Ganglion Phototherapy Using a Portable Radiation Device, for Destination Therapy of Drug-Refractory Ventricular Tachycardia. [PDF]

CJC Open
Okidono Y, Yamasaki H, Oda Y, Komatsu Y, Igarashi M, Ishizu T.   +5 more
europepmc   +1 more source

Cost Effectiveness of Left Ventricular Assist Devices (LVADs) as Destination Therapy: A Systematic Review. [PDF]

Pharmacoecon Open
Saygın Avşar T, Jackson L, Barton P, Beese S, Chidubem OO, Lim S, Quinn D, Price MJ, Moore DJ.   +8 more
europepmc   +1 more source

Work Absenteeism Due to a Chronic Disease [PDF]

Research on health-related work absenteeism focuses primarily on moral hazard issues but seldom discriminates between the types of illnesses that prompt workers to stay home or seek care. This paper focuses on chronic migraine, a common and acute illness
Guy Lacroix, Marie-Ève Brouard
core  

End-of-life decision-making and changing preferences in patients with a left ventricular assist device for destination therapy: insights from advance directives in Japan. [PDF]

J Artif Organs
Izumida T, Amiya E, Hatano M, Ishida J, Kanno M, Shimada A, Endo M, Ando M, Kimura M, Shimada S, Ono M, Takeda N.   +11 more
europepmc   +1 more source

Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial [PDF]

, 2018
et al,, Itoh, Akinobu
core   +1 more source

Correction: Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study. [PDF]

PLoS One
Avşar TS, Jackson L, Barton P, Beese S, Lim HS, Quinn D, Price M, Moore DJ.   +7 more
europepmc   +1 more source